These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23423156)

  • 1. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy.
    Huang G; Chen H; Dong Y; Luo X; Yu H; Moore Z; Bey EA; Boothman DA; Gao J
    Theranostics; 2013; 3(2):116-26. PubMed ID: 23423156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.
    Ma X; Huang X; Moore Z; Huang G; Kilgore JA; Wang Y; Hammer S; Williams NS; Boothman DA; Gao J
    J Control Release; 2015 Feb; 200():201-11. PubMed ID: 25542645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored Beta-Lapachone Nanomedicines for Cancer-Specific Therapy.
    Li Y; Feng M; Guo T; Wang Z; Zhao Y
    Adv Healthc Mater; 2023 Aug; 12(20):e2300349. PubMed ID: 36970948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Fenton Reactors as a New Class of Oxidative Stress Amplifying Anticancer Therapeutic Agents.
    Kwon B; Han E; Yang W; Cho W; Yoo W; Hwang J; Kwon BM; Lee D
    ACS Appl Mater Interfaces; 2016 Mar; 8(9):5887-97. PubMed ID: 26888039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
    Kievit FM; Zhang M
    Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual responsive nitric oxide / β-lapachone co-delivery platform for redox imbalance-enhanced tumor therapy.
    Yang HZ; Chen JJ; Zhang L; Tian XL; Wang R; Pu L; Yu XQ; Zhang J
    Eur J Pharm Biopharm; 2024 Aug; 201():114348. PubMed ID: 38844097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective in vitro anticancer effect of superparamagnetic iron oxide nanoparticles loaded in hyaluronan polymeric micelles.
    Smejkalová D; Nešporová K; Huerta-Angeles G; Syrovátka J; Jirák D; Gálisová A; Velebný V
    Biomacromolecules; 2014 Nov; 15(11):4012-20. PubMed ID: 25268047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. eIF2 kinases mediate β-lapachone toxicity in yeast and human cancer cells.
    Menacho-Márquez M; Rodríguez-Hernández CJ; Villaronga MÁ; Pérez-Valle J; Gadea J; Belandia B; Murguía JR
    Cell Cycle; 2015; 14(4):630-40. PubMed ID: 25590579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells.
    Blanco E; Bey EA; Dong Y; Weinberg BD; Sutton DM; Boothman DA; Gao J
    J Control Release; 2007 Oct; 122(3):365-74. PubMed ID: 17574288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Antitumor Efficacy by a Cascade of Reactive Oxygen Species Generation and Drug Release.
    Wang S; Yu G; Wang Z; Jacobson O; Lin LS; Yang W; Deng H; He Z; Liu Y; Chen ZY; Chen X
    Angew Chem Int Ed Engl; 2019 Oct; 58(41):14758-14763. PubMed ID: 31429173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-lapachone significantly increases the effect of ionizing radiation to cause mitochondrial apoptosis via JNK activation in cancer cells.
    Park MT; Song MJ; Lee H; Oh ET; Choi BH; Jeong SY; Choi EK; Park HJ
    PLoS One; 2011; 6(10):e25976. PubMed ID: 21998736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy.
    Li LS; Bey EA; Dong Y; Meng J; Patra B; Yan J; Xie XJ; Brekken RA; Barnett CC; Bornmann WG; Gao J; Boothman DA
    Clin Cancer Res; 2011 Jan; 17(2):275-85. PubMed ID: 21224367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Lapachone Induces Acute Oxidative Stress in Rat Primary Astrocyte Cultures that is Terminated by the NQO1-Inhibitor Dicoumarol.
    Steinmeier J; Kube S; Karger G; Ehrke E; Dringen R
    Neurochem Res; 2020 Oct; 45(10):2442-2455. PubMed ID: 32789798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Lapachone Induces NAD(P)H:Quinone Oxidoreductase-1- and Oxidative Stress-Dependent Heat Shock Protein 90 Cleavage and Inhibits Tumor Growth and Angiogenesis.
    Wu Y; Wang X; Chang S; Lu W; Liu M; Pang X
    J Pharmacol Exp Ther; 2016 Jun; 357(3):466-75. PubMed ID: 27048660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
    Tassa C; Shaw SY; Weissleder R
    Acc Chem Res; 2011 Oct; 44(10):842-52. PubMed ID: 21661727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy.
    Yoon HY; Saravanakumar G; Heo R; Choi SH; Song IC; Han MH; Kim K; Park JH; Choi K; Kwon IC; Park K
    J Control Release; 2012 Jun; 160(3):692-8. PubMed ID: 22543013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species mediated theranostics using a Fenton reaction activable lipo-polymersome.
    You C; Gao Z; Wu H; Sun K; Ning L; Lin F; Sun B; Wang F
    J Mater Chem B; 2019 Jan; 7(2):314-323. PubMed ID: 32254556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of superparamagnetic iron oxide nanoparticles on photosynthesis and growth of the aquatic plant Lemna gibba.
    Barhoumi L; Oukarroum A; Taher LB; Smiri LS; Abdelmelek H; Dewez D
    Arch Environ Contam Toxicol; 2015 Apr; 68(3):510-20. PubMed ID: 25392153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual pH-sensitive oxidative stress generating micellar nanoparticles as a novel anticancer therapeutic agent.
    Park S; Kwon B; Yang W; Han E; Yoo W; Kwon BM; Lee D
    J Control Release; 2014 Dec; 196():19-27. PubMed ID: 25278257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.
    Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T
    Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.